Hospital Garcia de Orta EPE Almada - Portugal.
Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Universidade de Lisboa Lisbon, Portugal.
Arq Bras Cardiol. 2020 Jan;114(1):1-8. doi: 10.36660/abc.20180194.
Infective endocarditis (IE) is associated with severe complications and high mortality. The assessment of mortality rates and predictors for fatal events is important to identify modifiable factors related to the pattern of treatment, in order to improve outcomes.
We sought to evaluate clinical outcomes of patients with IE and to determine predictors of in-hospital mortality.
Retrospective single-center study including patients with IE admitted during a 10-year period (2006-2015). Data on comorbidities, clinical presentation, microbiology and clinical outcomes during hospitalization were evaluated. Risk factors of in-hospital death were analyzed. A p-value < 0.05 was considered significant.
A total of 134 cases were included (73% males, mean age of 61 ± 16 years-old). Half of them had previous valvular heart disease. Healthcare-associated IE and negative blood-cultures occurred in 22% and prosthetic IE in 25%. The aortic valve was the one most often affected by infection. Staphylococcus aureus was the most commonly isolated microorganism. Forty-four (32.8%) patients underwent cardiac surgery. The in-hospital mortality rate was 31.3% (42 patients). The identified risk factors for in-hospital mortality were Staphylococcus aureus etiology (OR 6.47; 95% CI: 1.07-39.01; p = 0.042), negative blood-cultures (OR 9.14; 95% CI: 1.42-58.77; p = 0.02), evidence of valve obstruction in echocardiography (OR 8.57; 95% CI: 1.11-66.25; p = 0.039), clinical evolution with heart failure (OR 4.98; 95%CI: 1.31-18.92; p = 0.018) or septic shock (OR 20.26; 95% CI: 4.04-101.74; p < 0.001). Cardiac surgery was a protective factor of mortality (OR 0.14; 95% CI 0.03-0.65; p = 0.012).
The risk factors for in-hospital mortality were clinical (heart failure, septic shock), evidence of valve obstruction in echocardiography, Staphylococcus aureus etiology or negative blood cultures. Invasive treatment by surgery significantly decreased the mortality risk.
感染性心内膜炎(IE)与严重并发症和高死亡率相关。评估死亡率和致命事件的预测因素对于确定与治疗模式相关的可改变因素至关重要,以便改善预后。
我们旨在评估 IE 患者的临床结局,并确定院内死亡率的预测因素。
这是一项回顾性单中心研究,纳入了 10 年间(2006 年至 2015 年)住院的 IE 患者。评估了合并症、临床表现、微生物学和住院期间临床结局的数据。分析了院内死亡的危险因素。p 值<0.05 被认为具有统计学意义。
共纳入 134 例患者(73%为男性,平均年龄 61±16 岁)。其中一半患者有既往瓣膜性心脏病。医疗保健相关性 IE 和血培养阴性分别占 22%和 25%,主动脉瓣是最常受感染的瓣膜。金黄色葡萄球菌是最常见的分离微生物。44 例(32.8%)患者接受了心脏手术。院内死亡率为 31.3%(42 例)。确定的院内死亡的危险因素包括金黄色葡萄球菌病因(OR 6.47;95%CI:1.07-39.01;p=0.042)、血培养阴性(OR 9.14;95%CI:1.42-58.77;p=0.02)、超声心动图显示瓣膜阻塞的证据(OR 8.57;95%CI:1.11-66.25;p=0.039)、心力衰竭(OR 4.98;95%CI:1.31-18.92;p=0.018)或感染性休克(OR 20.26;95%CI:4.04-101.74;p<0.001)的临床进展。心脏手术是死亡率的保护因素(OR 0.14;95%CI 0.03-0.65;p=0.012)。
院内死亡率的危险因素包括临床(心力衰竭、感染性休克)、超声心动图显示瓣膜阻塞的证据、金黄色葡萄球菌病因或血培养阴性。手术的侵入性治疗显著降低了死亡率风险。